Immunostimulant Composition Comprising At Least One Toll-Like Receptor 7 Or Toll-Like Receptor 8 Agonist And A Toll-Like Receptor 4 Agonist
AssigneeSanofi Pasteur Limited
InventorsNicolas Burdin, Jean Haensler
Life of this patent
Estimating the term…
Abstract
The invention relates to an immunostimulant composition comprising at least one Toll-like receptor 7 or Toll-like receptor 8 agonist and a receptor 4 agonist. The inventive composition can also comprise a vaccine antigen.
Claims8
An immunostimulant composition comprising at least one agonist of the Toll-like 7 receptor or of the Toll-like 8 receptor, wherein the composition additionally comprises an agonist of the Toll-like 4 receptor.
The immunostimulant composition as claimed in the preceding claim, wherein the agonist of the Toll-like 7 receptor or of the Toll-like 8 receptor is a compound different from the agonist of the Toll-like 4 receptor.
The immunostimulant composition as claimed in the preceding claim, wherein the imidazoquinolineamine derivative is 4-amino-2-ethoxymethyl-α,α-dimethyl-1-H-imidazo[4,5e]quinoline-1-ethanol.
-8. (canceled)
Dependencies are inferred from the claim text.